Sabra Health Care REIT (SBRA) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $0.15
- Estimate
- $0.17
- Surprise
- -10.2%
- Score at report (before → after)
- 6.2 → 6.1/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Sabra Health Care REIT (SBRA) missed the $0.17 estimate with diluted EPS of $0.15 — a large 10.2% shortfall. TrendMatrix's engine moved from Buy (Wait) (6.2/10) to Hold at 6.1/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates SBRA Hold at 5.7/10.
0 of the last 4 quarters beat the estimate; this quarter's -10.2% surprise compares with a -4.0% four-quarter average. Next scheduled report: 2026-11-04.
What supports the rating
- Positive news sentiment (+0.67)
- Strong growth profile
What argues against it
- Analyst target reached - limited upside remaining
- V7 low-quality RISK_OFF penalty: -0.5 (Q=5.2)
- Sector modifier (Real Estate): -1.2
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $20.93
- Price target
- $24.07
- Stop
- $20.23
- Upside to target
- +15.0%
The stock trades at 80.2× trailing but 25.8× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.
SBRA at TrendMatrix's latest read
REIT quarters hinge on occupancy, rate exposure, and FFO rather than headline EPS, which mechanically distorts under depreciation.
- Industry
- REIT - Healthcare Facilities
- Market cap
- $5.33B
- P/E (fwd)
- 25.8
- P/E (ttm)
- 80.2
- 52-week range
- $17.17–$22.77
- Off 52-week high
- 8.1%
- RSI (14)
- 63
- Volume vs avg
- 0.96×
- Score today
- 5.7/10